{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:04:46Z","timestamp":1762142686638,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejphar.2012.02.037","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T06:16:26Z","timestamp":1331014586000},"page":"186-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of proangiotensin-12 infused continuously over 14 days in conscious rats"],"prefix":"10.1016","volume":"683","author":[{"given":"Yoichi","family":"Komatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kuwasako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.02.037_bb0005","doi-asserted-by":"crossref","first-page":"e15759","DOI":"10.1371\/journal.pone.0015759","article-title":"Uptake and metabolism of the novel peptide angiotensin-(1\u201312) by neonatal cardiac myocytes","volume":"6","author":"Ahmad","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2012.02.037_bb0010","doi-asserted-by":"crossref","first-page":"H763","DOI":"10.1152\/ajpheart.00345.2010","article-title":"Angiotensin-(1\u201312) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus","volume":"299","author":"Arnold","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0015","first-page":"679","article-title":"Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12","volume":"61","author":"Bujak-Gizycka","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112768","article-title":"Circulating and tissue angiotensin systems","volume":"79","author":"Campbell","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0025","first-page":"e139","article-title":"Distinct processing pathways for the novel peptide angiotensin-(1\u201312) in the serum and kidney of the hypertensive mRen2.Lewis rat (Abstract)","volume":"50","author":"Chappell","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.02.037_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.RES.39.6.779","article-title":"Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs","volume":"39","author":"Cowley","year":"1976","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0035","doi-asserted-by":"crossref","first-page":"H1284","DOI":"10.1152\/ajpheart.1991.261.4.H1284","article-title":"Neural and humoral mechanisms of angiotensin-dependent hypertension","volume":"261","author":"Cox","year":"1991","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.HYP.16.4.363","article-title":"Angiotensin I converting enzyme and the changes in our concepts through the years","volume":"16","author":"Erd\u00f6s","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.02.037_bb0045","doi-asserted-by":"crossref","first-page":"H1184","DOI":"10.1152\/ajpheart.01114.2008","article-title":"Differential regulation of angiotensin-(1\u201312) in plasma and cardiac tissue in response to bilateral nephrectomy","volume":"296","author":"Ferrario","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0050","doi-asserted-by":"crossref","first-page":"H2614","DOI":"10.1152\/ajpheart.91521.2007","article-title":"Localization of the novel angiotensin peptide, angiotensin-(1\u201312), in heart and kidney of hypertensive and normotensive rats","volume":"294","author":"Jessup","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin\u2013angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0060","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1152\/ajpregu.1996.271.1.R200","article-title":"Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency","volume":"271","author":"Li","year":"1996","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0065","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbrc.2006.09.146","article-title":"Isolation and identification of proangiotensin-12, a possible component of the renin\u2013angiotensin system","volume":"350","author":"Nagata","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.peptides.2010.02.008","article-title":"Plasma and tissue levels of proangiotensin-12 and components of the renin\u2013angiotensin system (RAS) following low- or high-salt feeding in rats","volume":"31","author":"Nagata","year":"2010","journal-title":"Peptides"},{"issue":"9583","key":"10.1016\/j.ejphar.2012.02.037_bb0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(07)61124-6","article-title":"Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial","volume":"370","author":"Oparil","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2012.02.037_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cvr\/cvp003","article-title":"Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics","volume":"82","author":"Prosser","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0085","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.peptides.2010.05.009","article-title":"Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system","volume":"31","author":"Prosser","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2012.02.037_bb0090","doi-asserted-by":"crossref","first-page":"H2242","DOI":"10.1152\/ajpheart.00175.2008","article-title":"Angiotensin-(1\u201312) is an alternate substrate for angiotensin peptide production in the heart","volume":"294","author":"Trask","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cardiores.2004.11.004","article-title":"Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats","volume":"65","author":"Tsuruda","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"Suppl. I","key":"10.1016\/j.ejphar.2012.02.037_bb0100","first-page":"177","article-title":"Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase","volume":"14","author":"Urata","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0895-7061(95)00349-5","article-title":"Chymase-dependent angiotensin II forming systems in humans","volume":"9","author":"Urata","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2012.02.037_bb0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00109-008-0340-4","article-title":"New angiotensins","volume":"86","author":"Varagic","year":"2008","journal-title":"J. Mol. Med. (Berl)"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:01:30Z","timestamp":1762142490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0014299912002002"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.02.037","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of proangiotensin-12 infused continuously over 14days in conscious rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}